- Filed
- Mar 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 11, 2025 | 32.2M sh |
| Short Term Investments | Q1 2025 · Jan 31, 2025 | $16.2M |
| Short Term Investments | Q1 2025 · Oct 31, 2024 | $18.65M |
| Cash And Equivalents | Q1 2025 · Jan 31, 2025 | $1.05M |
| Cash And Equivalents | Q1 2025 · Oct 31, 2024 | $1.27M |
| Stockholders Equity | Q1 2025 · Jan 31, 2025 | $17.85M |
| Stockholders Equity | Q1 2025 · Oct 31, 2024 | $20M |
| Current Liabilities | Q1 2025 · Jan 31, 2025 | $2M |
| Current Liabilities | Q1 2025 · Oct 31, 2024 | $2.5M |
| Total Liabilities | Q1 2025 · Jan 31, 2025 | $2.19M |
| Total Liabilities | Q1 2025 · Oct 31, 2024 | $2.7M |
| Current Assets | Q1 2025 · Jan 31, 2025 | $18.69M |
| Current Assets | Q1 2025 · Oct 31, 2024 | $21.36M |
| Total Assets | Q1 2025 · Jan 31, 2025 | $18.91M |
| Total Assets | Q1 2025 · Oct 31, 2024 | $21.59M |
| Shares Diluted restated | Q1 2025 · Jan 31, 2024 | 31.45M sh |
| Operating Cash Flow | Q1 2025 · Jan 31, 2024 | −$2.31M |
| Eps Diluted restated | Q1 2025 · Jan 31, 2024 | −$0.10 |
| Eps Basic restated | Q1 2025 · Jan 31, 2024 | −$0.10 |
| Rd Expense | Q1 2025 · Jan 31, 2024 | $1.35M |
| Net Income | Q1 2025 · Jan 31, 2024 | −$3.26M |
| Operating Income | Q1 2025 · Jan 31, 2024 | −$3.61M |